Article info

Download PDFPDF
Macular vessel reduction as predictor for recurrence of macular oedema requiring repeat intravitreal ranibizumab injection in eyes with branch retinal vein occlusion

Authors

  1. Correspondence to Dr Taiji Hasegawa, Department of Ophthalmology, Tokyo Women’s Medical University, Tokyo 162-8666, Japan; hasegawa.taiji{at}twmu.ac.jp
View Full Text

Citation

Hasegawa T, Takahashi Y, Maruko I, et al
Macular vessel reduction as predictor for recurrence of macular oedema requiring repeat intravitreal ranibizumab injection in eyes with branch retinal vein occlusion

Publication history

  • Received June 21, 2018
  • Revised November 8, 2018
  • Accepted November 19, 2018
  • First published December 4, 2018.
Online issue publication 
September 19, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.